Cellectar Biosciences Inc (CLRB) — Cash Flow-to-Debt Ratio
Cellectar Biosciences Inc (CLRB) has a Cash Flow-to-Debt Ratio of -0.86x as of December 2025, meaning its operating cash flow of $-4.34 Million could theoretically repay -1% of its total liabilities ($5.06 Million) in one year. Explore CLRB long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cellectar Biosciences Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Cellectar Biosciences Inc across 22 annual periods. Also explore Cellectar Biosciences Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Cellectar Biosciences Inc (2004–2025)
Year-by-year debt coverage analysis for Cellectar Biosciences Inc. For market capitalisation and broader financial context, see CLRB market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.57x | $-23.12 Million | $5.06 Million | ▼ -7.4% |
| 2024 | -4.26x | $-47.58 Million | $11.18 Million | ▼ -239.9% |
| 2023 | -1.25x | $-32.38 Million | $25.85 Million | ▲ +40.1% |
| 2022 | -2.09x | $-25.22 Million | $12.05 Million | ▲ +61.5% |
| 2021 | -5.43x | $-22.57 Million | $4.16 Million | ▼ -50.6% |
| 2020 | -3.60x | $-13.93 Million | $3.86 Million | ▲ +1.6% |
| 2019 | -3.66x | $-11.69 Million | $3.19 Million | ▲ +42.6% |
| 2018 | -6.38x | $-11.44 Million | $1.79 Million | ▼ -22.6% |
| 2017 | -5.21x | $-11.02 Million | $2.12 Million | ▼ -12.2% |
| 2016 | -4.64x | $-8.28 Million | $1.78 Million | ▼ -236.0% |
| 2015 | -1.38x | $-8.21 Million | $5.95 Million | ▲ +58.2% |
| 2014 | -3.31x | $-8.84 Million | $2.67 Million | ▼ -84.8% |
| 2013 | -1.79x | $-9.15 Million | $5.12 Million | ▲ +64.1% |
| 2012 | -4.99x | $-6.59 Million | $1.32 Million | ▲ +9.6% |
| 2011 | -5.52x | $-5.97 Million | $1.08 Million | ▲ +11.3% |
| 2010 | -6.22x | $-7.80 Million | $1.25 Million | ▼ -1999.9% |
| 2009 | -0.30x | $-10.62 Million | $35.83 Million | ▲ +87.9% |
| 2008 | -2.46x | $-17.33 Million | $7.05 Million | ▼ -209.9% |
| 2007 | -0.79x | $-13.47 Million | $16.98 Million | ▲ +83.9% |
| 2006 | -4.93x | $-6.47 Million | $1.31 Million | ▲ +55.4% |
| 2005 | -11.05x | $-2.40 Million | $217.16K | ▼ -12553.9% |
| 2004 | -0.09x | $-389.18K | $4.46 Million | — |